An Observational Study of Adjunctive Artisanal Cannabidiol Use by Adults with Treatment Resistant Epilepsies: Behavioral and Urinalysis Data

Author:

Brett Barbara1,Conroy Matthieu2,Doshi Hardik3,Lowe Matthew X.4,Kalcheff-Korn Sasha4,Jackson Heather4

Affiliation:

1. Colorado State University - Pueblo

2. United States Army Medical Research Institute of Chemical Defense

3. Cape Fear Valley Medical Center

4. Realm of Caring

Abstract

AbstractBackground For approximately 30% of people with epilepsy, seizures are not well-controlled by antiepileptic drugs. This condition, called treatment resistant epilepsy (TRE), is associated with increased morbidity and mortality, and substantially impacts the quality of life of both the individual and their family. Non-responsiveness to AEDs leads many people with TRE to seek alternative therapies, such as cannabinoid-based medication, particularly cannabidiol (CBD), with or without medical or professional advice. This is due in part to widespread reporting in the media on the benefits of CBD for seizures in some forms of epilepsy. Methods Ten adults with TRE, opting to add CBD to their existing treatment regime, participated in this prospective, observational, longitudinal study. We hypothesized that adjunctive CBD use would positively impact participants’ quality of life and psychological well-being. Participants were followed for a period of approximately six months – for approximately one month prior to the initiation of CBD use and approximately five months after. At three time points, participants provided urine samples and completed behavioral questionnaires that assessed quality of life, anxiety/depression, and adverse events. Results Analyses showed a statistically significant improvement in quality of life, a statistically significant decrease in anxiety symptoms, and a statistically significant decrease in the experience of adverse events over time (p < 0.05). Urinalysis revealed the majority of participants had no CBD/metabolites in their system at the beginning of the study, and confirmed the presence of CBD/metabolites in participants’ urine after CBD was added to their treatment regime. Conclusion These results suggest that adjunctive use of artisanal CBD may be beneficial for the behavioral and psychological symptoms of TRE and may improve medication tolerability.

Publisher

Research Square Platform LLC

Reference85 articles.

1. Stroke N. I.N.D.S. The Epilepsies and Seizures: Hope and Help through Research. 2015.

2. Organization. T.W.H. (n.d.).

3. Prevention CDC. Epilepsy 2020.

4. Some aspects of prognosis in the epilepsies: a review;Sander JW;Epilepsia,1993

5. Cannabinoids in the Treatment of Epilepsy;Friedman D;N Engl J Med,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3